These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lassa fever in Panguma Hospital, Sierra Leone, 1973-6. Keane E; Gilles HM Br Med J; 1977 May; 1(6073):1399-402. PubMed ID: 861652 [No Abstract] [Full Text] [Related]
4. Lassa virus antibodies in hospital personnel in western Liberia. Frame JD; Casals J; Dennis EA Trans R Soc Trop Med Hyg; 1979; 73(2):219-24. PubMed ID: 382467 [TBL] [Abstract][Full Text] [Related]
5. Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. Branco LM; Boisen ML; Andersen KG; Grove JN; Moses LM; Muncy IJ; Henderson LA; Schieffellin JS; Robinson JE; Bangura JJ; Grant DS; Raabe VN; Fonnie M; Zaitsev EM; Sabeti PC; Garry RF Virol J; 2011 Aug; 8():404. PubMed ID: 21843352 [TBL] [Abstract][Full Text] [Related]
6. A prospective study of the epidemiology and ecology of Lassa fever. McCormick JB; Webb PA; Krebs JW; Johnson KM; Smith ES J Infect Dis; 1987 Mar; 155(3):437-44. PubMed ID: 3805771 [TBL] [Abstract][Full Text] [Related]
7. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Branco LM; Grove JN; Boisen ML; Shaffer JG; Goba A; Fullah M; Momoh M; Grant DS; Garry RF Virol J; 2011 Oct; 8():478. PubMed ID: 22023795 [TBL] [Abstract][Full Text] [Related]
8. Lassa fever in children in Sierra Leone, West Africa. Webb PA; McCormick JB; King IJ; Bosman I; Johnson KM; Elliott LH; Kono GK; O'Sullivan R Trans R Soc Trop Med Hyg; 1986; 80(4):577-82. PubMed ID: 3810792 [TBL] [Abstract][Full Text] [Related]
9. Endemic Lassa fever in Liberia. II. Serological and virological findings in hospital patients. Frame JD; Jahrling PB; Yalley-Ogunro JE; Monson MH Trans R Soc Trop Med Hyg; 1984; 78(5):656-60. PubMed ID: 6390808 [TBL] [Abstract][Full Text] [Related]
10. Lassa Fever among Children in Eastern Province, Sierra Leone: A 7-year Retrospective Analysis (2012-2018). Samuels RJ; Moon TD; Starnes JR; Alhasan F; Gbakie M; Goba A; Koroma V; Momoh M; Sandi JD; Garry RF; Engel EJ; Shaffer JG; Schieffelin JS; Grant DS Am J Trop Med Hyg; 2020 Nov; 104(2):585-592. PubMed ID: 33241780 [TBL] [Abstract][Full Text] [Related]
11. Boosting understanding of Lassa Fever virus epidemiology: Field testing a novel assay to identify past Lassa Fever virus infection in blood and oral fluids of survivors and unexposed controls in Sierra Leone. Akpogheneta O; Dicks S; Grant D; Kanneh Z; Jusu B; Edem-Hotah J; Kanneh L; Alhasan F; Gbakie M; Schieffelin J; Ijaz S; Tedder R; Bower H PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009255. PubMed ID: 33788861 [TBL] [Abstract][Full Text] [Related]
12. Strain-specific antibody response to Lassa virus in the local population of west Africa. Emmerich P; Günther S; Schmitz H J Clin Virol; 2008 May; 42(1):40-4. PubMed ID: 18164653 [TBL] [Abstract][Full Text] [Related]
13. Endemic Lassa fever in Liberia. V. Distribution of Lassa virus activity in Liberia: hospital staff surveys. Frame JD; Yalley-Ogunro JE; Hanson AP Trans R Soc Trop Med Hyg; 1984; 78(6):761-3. PubMed ID: 6398529 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study. Grant DS; Engel EJ; Roberts Yerkes N; Kanneh L; Koninga J; Gbakie MA; Alhasan F; Kanneh FB; Kanneh IM; Kamara FK; Momoh M; Yillah MS; Foday M; Okoli A; Zeoli A; Weldon C; Bishop CM; Zheng C; Hartnett J; Chao K; Shore K; Melnik LI; Mucci M; Bond NG; Doyle P; Yenni R; Podgorski R; Ficenec SC; Moses L; Shaffer JG; Garry RF; Schieffelin JS PLoS Negl Trop Dis; 2023 Feb; 17(2):e0010938. PubMed ID: 36758101 [TBL] [Abstract][Full Text] [Related]
15. Health seeking behavior after the 2013-16 Ebola epidemic: Lassa fever as a metric of persistent changes in Kenema District, Sierra Leone. Koch MR; Kanneh L; Wise PH; Kurina LM; Alhasan F; Garry RF; Schieffelin JS; Shaffer JG; Grant DS PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009576. PubMed ID: 34260615 [TBL] [Abstract][Full Text] [Related]
16. Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen. Lukashevich IS; Clegg JC; Sidibe K J Med Virol; 1993 Jul; 40(3):210-7. PubMed ID: 8355019 [TBL] [Abstract][Full Text] [Related]
17. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues. Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional study. Kernéis S; Koivogui L; Magassouba N; Koulemou K; Lewis R; Aplogan A; Grais RF; Guerin PJ; Fichet-Calvet E PLoS Negl Trop Dis; 2009 Nov; 3(11):e548. PubMed ID: 19924222 [TBL] [Abstract][Full Text] [Related]
19. Lassa fever in children. Sharp PC J Infect; 1982 Jan; 4(1):73-7. PubMed ID: 7185979 [No Abstract] [Full Text] [Related]
20. Clinical, epidemiologic, and therapeutic aspects of Lassa fever. McCormick JB Med Microbiol Immunol; 1986; 175(2-3):153-5. PubMed ID: 3724661 [No Abstract] [Full Text] [Related] [Next] [New Search]